speb/financial-data huggingface dataset:
DDS cash_flow (quarterly, 2025-04-30) — Change In Income Tax Payable: 50400000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Inventory: -297236000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: 11721000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Payable: 314008000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 314008000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Receivables: -1235000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Tax Payable: 50400000.00
DDS cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 27258000.00
DDS cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -1235000.00
DDS cash_flow (quarterly, 2025-04-30) — Changes In Cash: 182650000.00
DDS balance_sheet (quarterly, 2025-04-30) — Common Stock: 1241000.00
DDS cash_flow (quarterly, 2025-04-30) — Common Stock Dividend Paid: -3976000.00
DDS balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 1857885000.00
DDS cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -98001000.00
DDS income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 857691000.00
DDS balance_sheet (quarterly, 2025-04-30) — Current Assets: 2768116000.00
DDS balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 10810000.00
DDS balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 10810000.00
DDS balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 1146775000.00
DDS cash_flow (quarterly, 2025-04-30) — Depreciation: 44853000.00
DDS cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 44853000.00
DDS income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 44485000.00
DDS cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 44853000.00
DDS income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 44485000.00
DDS income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 15800000.00
DDS income_statement (quarterly, 2025-04-30) — Diluted EPS: 10.39
DDS income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — EBIT: 218509000.00
DDS income_statement (quarterly, 2025-04-30) — EBITDA: 263362000.00
DDS income_statement (quarterly, 2025-04-30) — Earnings From Equity Interest Net Of Tax: 0.00
DDS cash_flow (quarterly, 2025-04-30) — End Cash Position: 900504000.00
DDS cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -105260000.00
DDS balance_sheet (quarterly, 2025-04-30) — Finished Goods: 1469283000.00
DDS cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 215779000.00
DDS income_statement (quarterly, 2025-04-30) — Gain On Sale Of Ppe: 59000.00
DDS balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: -49043000.00
DDS income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 426286000.00
DDS balance_sheet (quarterly, 2025-04-30) — Gross PPE: 3824150000.00
DDS income_statement (quarterly, 2025-04-30) — Gross Profit: 689280000.00
DDS balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 79279000.00
DDS income_statement (quarterly, 2025-04-30) — Interest Income: 822000.00
DDS income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 822000.00
DDS balance_sheet (quarterly, 2025-04-30) — Inventory: 1469283000.00
DDS balance_sheet (quarterly, 2025-04-30) — Invested Capital: 2379479000.00
DDS cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: 55278000.00
DDS balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 21540000.00
DDS balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 521594000.00
DDS balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 543134000.00
DDS cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -98001000.00
DDS income_statement (quarterly, 2025-04-30) — Net Income: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 163817000.00
DDS cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 163817000.00
DDS income_statement (quarterly, 2025-04-30) — Net Interest Income: 822000.00
DDS cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 70424000.00
DDS income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 822000.00
DDS cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -3283000.00
DDS cash_flow (quarterly, 2025-04-30) — Net Other Investing Changes: 1707000.00
DDS balance_sheet (quarterly, 2025-04-30) — Net PPE: 1008494000.00
DDS cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -16853000.00
DDS balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 1857885000.00
DDS balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Assets: 71275000.00
DDS balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Assets: 71275000.00
DDS income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 263303000.00
DDS income_statement (quarterly, 2025-04-30) — Normalized Income: 163771771.46
DDS cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 232632000.00
DDS cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: -59000.00
DDS income_statement (quarterly, 2025-04-30) — Operating Income: 218509000.00
DDS income_statement (quarterly, 2025-04-30) — Operating Revenue: 1546971000.00
DDS balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 15600000.00
DDS balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 82906000.00
DDS balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: -49043000.00
DDS income_statement (quarterly, 2025-04-30) — Other Gand A: 421690000.00
DDS income_statement (quarterly, 2025-04-30) — Other Income Expense: -5634000.00
DDS cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: -3237000.00
DDS balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 59139000.00
DDS balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 359230000.00
DDS income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: -5693000.00
DDS balance_sheet (quarterly, 2025-04-30) — Other Properties: 3824150000.00
DDS balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 258488000.00
DDS balance_sheet (quarterly, 2025-04-30) — Payables: 1135965000.00
DDS balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 1135965000.00
DDS income_statement (quarterly, 2025-04-30) — Pretax Income: 213697000.00
DDS cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: -212389000.00
DDS cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -16853000.00
DDS balance_sheet (quarterly, 2025-04-30) — Receivables: 56935000.00
DDS income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 857323000.00
DDS income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 44853000.00
DDS income_statement (quarterly, 2025-04-30) — Rent And Landing Fees: 4596000.00
DDS income_statement (quarterly, 2025-04-30) — Rent Expense Supplemental: 4596000.00
DDS cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -98001000.00
DDS balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 6387941000.00
DDS cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 282813000.00
DDS income_statement (quarterly, 2025-04-30) — Selling General And Administration: 426286000.00
DDS balance_sheet (quarterly, 2025-04-30) — Share Issued: 124028346.00
DDS income_statement (quarterly, 2025-04-30) — Special Income Charges: 59000.00
DDS balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 1857885000.00
DDS balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 1857885000.00
DDS income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 13771.46
DDS income_statement (quarterly, 2025-04-30) — Tax Provision: 49880000.00
DDS income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.23
DDS balance_sheet (quarterly, 2025-04-30) — Total Assets: 3907024000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 2379479000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Debt: 553944000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 1857885000.00
DDS income_statement (quarterly, 2025-04-30) — Total Expenses: 1328462000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 2049139000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 1138908000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 902364000.00
DDS balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 79279000.00
DDS income_statement (quarterly, 2025-04-30) — Total Unusual Items: 59000.00
DDS income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: 59000.00
DDS balance_sheet (quarterly, 2025-04-30) — Treasury Shares Number: 108428346.00
DDS balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 5453782000.00
DDS balance_sheet (quarterly, 2025-04-30) — Working Capital: 1621341000.00
DDS income_statement (quarterly, 2025-07-31) — +Operating Expense: 483375000.00
DDS income_statement (quarterly, 2025-07-31) — +Total Revenue: 1536003000.00
DDS balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 761226000.00
DDS balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 52212000.00
DDS balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -2847558000.00
DDS balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 972855000.00
DDS income_statement (quarterly, 2025-07-31) — Basic Average Shares: 15600000.00
DDS income_statement (quarterly, 2025-07-31) — Basic EPS: 4.66
DDS cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 900504000.00
DDS cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -26674000.00
DDS balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 29509000.00
DDS balance_sheet (quarterly, 2025-07-31) — Capital Stock: 1241000.00
DDS balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 1012011000.00
DDS balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 1211823000.00
DDS cash_flow (quarterly, 2025-07-31) — Cash Dividends Paid: -3924000.00
DDS cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -13722000.00
DDS cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: 38468000.00
DDS cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 86761000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Account Payable: -288130000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Income Tax Payable: 13166000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Inventory: 249518000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: -3173000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Payable: -274964000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: -274964000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Receivables: 4723000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Tax Payable: 13166000.00
DDS cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -23896000.00
DDS cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: 4723000.00
DDS cash_flow (quarterly, 2025-07-31) — Changes In Cash: 111507000.00
DDS balance_sheet (quarterly, 2025-07-31) — Common Stock: 1241000.00
DDS cash_flow (quarterly, 2025-07-31) — Common Stock Dividend Paid: -3924000.00
DDS balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 1919112000.00
DDS cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -9755000.00
DDS income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 959306000.00
DDS balance_sheet (quarterly, 2025-07-31) — Current Assets: 2572080000.00
DDS balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 10474000.00
DDS balance_sheet (quarterly, 2025-07-31) — Current Debt: 96000000.00
DDS balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 106474000.00
DDS balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 958712000.00
DDS cash_flow (quarterly, 2025-07-31) — Depreciation: 45036000.00
DDS cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 45036000.00
DDS income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 44659000.00
DDS cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 45036000.00
DDS income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 44659000.00
DDS income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 15600000.00
DDS income_statement (quarterly, 2025-07-31) — Diluted EPS: 4.66
DDS income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — EBIT: 93322000.00
DDS income_statement (quarterly, 2025-07-31) — EBITDA: 138358000.00
DDS cash_flow (quarterly, 2025-07-31) — End Cash Position: 1012011000.00
DDS cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -13722000.00
DDS balance_sheet (quarterly, 2025-07-31) — Finished Goods: 1219765000.00
DDS cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 60087000.00
DDS income_statement (quarterly, 2025-07-31) — Gain On Sale Of Ppe: 4841000.00
DDS balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: -48235000.00
DDS income_statement (quarterly, 2025-07-31) — General And Administrative Expense: 438716000.00
DDS balance_sheet (quarterly, 2025-07-31) — Gross PPE: 3832181000.00
DDS income_statement (quarterly, 2025-07-31) — Gross Profit: 576697000.00
DDS balance_sheet (quarterly, 2025-07-31) — Income Tax Payable: 91012000.00
DDS income_statement (quarterly, 2025-07-31) — Interest Income: 1457000.00
DDS income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 1457000.00
DDS balance_sheet (quarterly, 2025-07-31) — Inventory: 1219765000.00
DDS balance_sheet (quarterly, 2025-07-31) — Invested Capital: 2440733000.00
DDS cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: 38468000.00
DDS balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 19035000.00
DDS balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 425621000.00
DDS balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 444656000.00
DDS cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -9755000.00
DDS income_statement (quarterly, 2025-07-31) — Net Income: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 72835000.00
DDS cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 72835000.00
DDS income_statement (quarterly, 2025-07-31) — Net Interest Income: 1457000.00
DDS cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: 61049000.00
DDS income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 1457000.00
DDS cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -43000.00
DDS cash_flow (quarterly, 2025-07-31) — Net Other Investing Changes: 5843000.00
DDS balance_sheet (quarterly, 2025-07-31) — Net PPE: 984623000.00
DDS cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -26674000.00
DDS balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 1919112000.00
DDS balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Assets: 67714000.00
DDS balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Assets: 67714000.00
DDS income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 133517000.00
DDS income_statement (quarterly, 2025-07-31) — Normalized Income: 69107197.12
DDS cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 86761000.00
DDS cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: -4841000.00
DDS income_statement (quarterly, 2025-07-31) — Operating Income: 93322000.00
DDS income_statement (quarterly, 2025-07-31) — Operating Revenue: 1536003000.00
DDS balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 15600000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 88280000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Current Borrowings: 96000000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: -48235000.00
DDS income_statement (quarterly, 2025-07-31) — Other Gand A: 434165000.00
DDS income_statement (quarterly, 2025-07-31) — Other Income Expense: -194000.00
DDS cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: -2373000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 60056000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 361993000.00
DDS income_statement (quarterly, 2025-07-31) — Other Non Operating Income Expenses: -5035000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Properties: 3832181000.00
DDS balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 199812000.00
DDS balance_sheet (quarterly, 2025-07-31) — Payables: 852238000.00
DDS balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 852238000.00
DDS income_statement (quarterly, 2025-07-31) — Pretax Income: 94585000.00
DDS cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -61108000.00
DDS cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -26674000.00
DDS balance_sheet (quarterly, 2025-07-31) — Receivables: 52212000.00
DDS income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 958929000.00
DDS income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 45036000.00
DDS income_statement (quarterly, 2025-07-31) — Rent And Landing Fees: 4551000.00
DDS income_statement (quarterly, 2025-07-31) — Rent Expense Supplemental: 4551000.00
DDS cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -9755000.00
DDS balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 6456873000.00
DDS cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 122157000.00
DDS income_statement (quarterly, 2025-07-31) — Selling General And Administration: 438716000.00
DDS balance_sheet (quarterly, 2025-07-31) — Share Issued: 124052846.00
DDS income_statement (quarterly, 2025-07-31) — Special Income Charges: 4841000.00
DDS balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 1919112000.00
DDS balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 1919112000.00
DDS income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 1113197.12
DDS income_statement (quarterly, 2025-07-31) — Tax Provision: 21750000.00
DDS income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.23
DDS balance_sheet (quarterly, 2025-07-31) — Taxes Receivable: 0.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Assets: 3684473000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 2344733000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Debt: 551130000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 1919112000.00
DDS income_statement (quarterly, 2025-07-31) — Total Expenses: 1442681000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 1765361000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 1112393000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 806649000.00
DDS balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 91012000.00
DDS income_statement (quarterly, 2025-07-31) — Total Unusual Items: 4841000.00
DDS income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: 4841000.00
DDS balance_sheet (quarterly, 2025-07-31) — Treasury Shares Number: 108452846.00
DDS balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 5463622000.00
DDS balance_sheet (quarterly, 2025-07-31) — Working Capital: 1613368000.00
DDS income_statement (quarterly, 2025-10-31) — +Operating Expense: 489138000.00
DDS income_statement (quarterly, 2025-10-31) — +Total Revenue: 1490973000.00
DDS balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 1213976000.00
DDS balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 44901000.00
DDS balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -2882759000.00
DDS balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 972855000.00
DDS income_statement (quarterly, 2025-10-31) — Basic Average Shares: 15600000.00
DDS income_statement (quarterly, 2025-10-31) — Basic EPS: 8.31
DDS cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 1012011000.00
DDS cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -30311000.00
DDS balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 26919000.00
DDS balance_sheet (quarterly, 2025-10-31) — Capital Stock: 1241000.00
DDS balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 1149201000.00
DDS balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 1334444000.00
DDS cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -3904000.00
DDS cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -3914000.00
DDS cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -45358000.00
DDS cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 186462000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Account Payable: 450661000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Income Tax Payable: 38201000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Inventory: -498306000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: 15962000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Payable: 488862000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 488862000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Receivables: 7311000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Tax Payable: 38201000.00
DDS cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 13829000.00
DDS cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: 7311000.00
DDS cash_flow (quarterly, 2025-10-31) — Changes In Cash: 137190000.00
DDS balance_sheet (quarterly, 2025-10-31) — Common Stock: 1241000.00
DDS cash_flow (quarterly, 2025-10-31) — Common Stock Dividend Paid: -3904000.00
DDS balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 2045046000.00
DDS cash_flow (quarterly, 2025-10-31) — Common Stock Payments: 0.00
DDS income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 831643000.00
DDS balance_sheet (quarterly, 2025-10-31) — Current Assets: 3169032000.00
DDS balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 10037000.00
DDS balance_sheet (quarterly, 2025-10-31) — Current Debt: 96000000.00
DDS balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 106037000.00
DDS balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 1445456000.00
DDS cash_flow (quarterly, 2025-10-31) — Depreciation: 44761000.00
DDS cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 44761000.00
DDS income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 44375000.00
DDS cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 44761000.00
DDS income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 44375000.00
DDS income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 15600000.00
DDS income_statement (quarterly, 2025-10-31) — Diluted EPS: 8.31
DDS income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — EBIT: 170192000.00
DDS income_statement (quarterly, 2025-10-31) — EBITDA: 214953000.00
DDS cash_flow (quarterly, 2025-10-31) — End Cash Position: 1149201000.00
DDS cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -3914000.00
DDS balance_sheet (quarterly, 2025-10-31) — Finished Goods: 1718071000.00
DDS cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 156151000.00
DDS income_statement (quarterly, 2025-10-31) — Gain On Sale Of Ppe: 577000.00
DDS balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -47427000.00
DDS income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 444763000.00
DDS balance_sheet (quarterly, 2025-10-31) — Gross PPE: 3853715000.00
DDS income_statement (quarterly, 2025-10-31) — Gross Profit: 659330000.00
DDS balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 125443000.00
DDS income_statement (quarterly, 2025-10-31) — Interest Income: 3076000.00
DDS income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 3076000.00
DDS balance_sheet (quarterly, 2025-10-31) — Inventory: 1718071000.00
DDS balance_sheet (quarterly, 2025-10-31) — Invested Capital: 2566693000.00
DDS cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -45358000.00
DDS balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 16882000.00
DDS balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 425647000.00
DDS balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 442529000.00
DDS cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: -32555000.00
DDS cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 0.00
DDS income_statement (quarterly, 2025-10-31) — Net Income: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 129810000.00
DDS cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 129810000.00
DDS income_statement (quarterly, 2025-10-31) — Net Interest Income: 3076000.00
DDS cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 15930000.00
DDS income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 3076000.00
DDS cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -10000.00
DDS cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: 1578000.00
DDS balance_sheet (quarterly, 2025-10-31) — Net PPE: 970956000.00
DDS cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -30311000.00
DDS balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 2045046000.00
DDS balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Assets: 65622000.00
DDS balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Assets: 65622000.00
DDS income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 214376000.00
DDS income_statement (quarterly, 2025-10-31) — Normalized Income: 129366303.71
DDS cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 186462000.00
DDS cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -577000.00
DDS income_statement (quarterly, 2025-10-31) — Operating Income: 170192000.00
DDS income_statement (quarterly, 2025-10-31) — Operating Revenue: 1490973000.00
DDS balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 15600000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 71616000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Current Borrowings: 96000000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -47427000.00
DDS income_statement (quarterly, 2025-10-31) — Other Gand A: 440409000.00
DDS income_statement (quarterly, 2025-10-31) — Other Income Expense: -4458000.00
DDS cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -1361000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 92455000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 365034000.00
DDS income_statement (quarterly, 2025-10-31) — Other Non Operating Income Expenses: -5035000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Properties: 3853715000.00
DDS balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 185243000.00
DDS balance_sheet (quarterly, 2025-10-31) — Payables: 1339419000.00
DDS balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 1339419000.00
DDS income_statement (quarterly, 2025-10-31) — Pretax Income: 168810000.00
DDS cash_flow (quarterly, 2025-10-31) — Purchase Of Business: -32555000.00
DDS cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: -122840000.00
DDS cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -30311000.00
DDS balance_sheet (quarterly, 2025-10-31) — Receivables: 44901000.00
DDS income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 831257000.00
DDS income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 44761000.00
DDS income_statement (quarterly, 2025-10-31) — Rent And Landing Fees: 4354000.00
DDS income_statement (quarterly, 2025-10-31) — Rent Expense Supplemental: 4354000.00
DDS cash_flow (quarterly, 2025-10-31) — Repurchase Of Capital Stock: 0.00
DDS balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 6581999000.00
DDS cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 138770000.00
DDS income_statement (quarterly, 2025-10-31) — Selling General And Administration: 444763000.00
DDS balance_sheet (quarterly, 2025-10-31) — Share Issued: 124352846.00
DDS income_statement (quarterly, 2025-10-31) — Special Income Charges: 577000.00
DDS balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 2045046000.00
DDS balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 2045046000.00
DDS income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 133303.71
DDS income_statement (quarterly, 2025-10-31) — Tax Provision: 39000000.00
DDS income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.23
DDS balance_sheet (quarterly, 2025-10-31) — Total Assets: 4298065000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 2470693000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Debt: 548566000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 2045046000.00
DDS income_statement (quarterly, 2025-10-31) — Total Expenses: 1320781000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 2253019000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 1129033000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 807563000.00
DDS balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 125443000.00
DDS income_statement (quarterly, 2025-10-31) — Total Unusual Items: 577000.00
DDS income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 577000.00
DDS balance_sheet (quarterly, 2025-10-31) — Treasury Shares Number: 108752846.00
DDS balance_sheet (quarterly, 2025-10-31) — Treasury Stock: 5463622000.00
DDS balance_sheet (quarterly, 2025-10-31) — Working Capital: 1723576000.00
DDS income_statement (annual, 2026-01-31) — +Operating Expense: 1957800000.00
DDS income_statement (quarterly, 2026-01-31) — +Operating Expense: 514516000.00
DDS income_statement (annual, 2026-01-31) — +Total Revenue: 6563336000.00
DDS income_statement (quarterly, 2026-01-31) — +Total Revenue: 1989389000.00
DDS balance_sheet (annual, 2026-01-31) — Accounts Payable: 570556000.00
DDS balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 570556000.00
DDS balance_sheet (annual, 2026-01-31) — Accounts Receivable: 39724000.00
DDS balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 39724000.00
DDS balance_sheet (annual, 2026-01-31) — Accumulated Depreciation: -2878784000.00
DDS balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -2878784000.00
DDS balance_sheet (annual, 2026-01-31) — Additional Paid In Capital: 975349000.00
DDS balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 975349000.00
DDS income_statement (annual, 2026-01-31) — Basic Average Shares: 15700000.00
DDS income_statement (quarterly, 2026-01-31) — Basic Average Shares: 15600000.00
DDS income_statement (annual, 2026-01-31) — Basic EPS: 36.42
DDS income_statement (quarterly, 2026-01-31) — Basic EPS: 13.05
DDS cash_flow (annual, 2026-01-31) — Beginning Cash Position: 717854000.00
DDS cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 1149201000.00
DDS balance_sheet (annual, 2026-01-31) — Buildings And Improvements: 3099243000.00
DDS balance_sheet (quarterly, 2026-01-31) — Buildings And Improvements: 3099243000.00
DDS cash_flow (annual, 2026-01-31) — Capital Expenditure: -93382000.00
DDS cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -19544000.00
DDS balance_sheet (annual, 2026-01-31) — Capital Lease Obligations: 35888000.00
DDS balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 35888000.00
DDS balance_sheet (annual, 2026-01-31) — Capital Stock: 1241000.00
DDS balance_sheet (quarterly, 2026-01-31) — Capital Stock: 1241000.00
DDS balance_sheet (annual, 2026-01-31) — Cash And Cash Equivalents: 861460000.00
DDS balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 861460000.00
DDS balance_sheet (annual, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 1072957000.00
DDS balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 1072957000.00
DDS cash_flow (annual, 2026-01-31) — Cash Dividends Paid: -484876000.00
DDS cash_flow (quarterly, 2026-01-31) — Cash Dividends Paid: -473072000.00
DDS cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Financing Activities: -595939000.00
DDS cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -473043000.00
DDS cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Investing Activities: 22537000.00
DDS cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -25851000.00
DDS cash_flow (annual, 2026-01-31) — Cash Flow From Continuing Operating Activities: 717008000.00
DDS cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 211153000.00
DDS cash_flow (annual, 2026-01-31) — Change In Account Payable: -2271000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Account Payable: -428410000.00
DDS cash_flow (annual, 2026-01-31) — Change In Income Tax Payable: -4570000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Income Tax Payable: -106337000.00
DDS cash_flow (annual, 2026-01-31) — Change In Inventory: -29051000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Inventory: 516973000.00
DDS cash_flow (annual, 2026-01-31) — Change In Other Current Assets: 22338000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Other Current Assets: -2172000.00
DDS cash_flow (annual, 2026-01-31) — Change In Payable: -6841000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Payable: -534747000.00
DDS cash_flow (annual, 2026-01-31) — Change In Payables And Accrued Expense: -6841000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -534747000.00
DDS cash_flow (annual, 2026-01-31) — Change In Receivables: 15976000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Receivables: 5177000.00
DDS cash_flow (annual, 2026-01-31) — Change In Tax Payable: -4570000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Tax Payable: -106337000.00
DDS cash_flow (annual, 2026-01-31) — Change In Working Capital: 2422000.00
DDS cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -14769000.00
DDS cash_flow (annual, 2026-01-31) — Changes In Account Receivables: 15976000.00
DDS cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: 5177000.00
DDS cash_flow (annual, 2026-01-31) — Changes In Cash: 143606000.00
DDS cash_flow (quarterly, 2026-01-31) — Changes In Cash: -287741000.00
DDS balance_sheet (annual, 2026-01-31) — Common Stock: 1241000.00
DDS balance_sheet (quarterly, 2026-01-31) — Common Stock: 1241000.00
DDS cash_flow (annual, 2026-01-31) — Common Stock Dividend Paid: -484876000.00
DDS cash_flow (quarterly, 2026-01-31) — Common Stock Dividend Paid: -473072000.00
DDS balance_sheet (annual, 2026-01-31) — Common Stock Equity: 1778970000.00
DDS balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 1778970000.00
DDS cash_flow (annual, 2026-01-31) — Common Stock Payments: -107756000.00
DDS cash_flow (quarterly, 2026-01-31) — Common Stock Payments: 0.00
DDS balance_sheet (annual, 2026-01-31) — Construction In Progress: 5827000.00
DDS balance_sheet (quarterly, 2026-01-31) — Construction In Progress: 5827000.00
DDS income_statement (annual, 2026-01-31) — Cost Of Revenue: 3916862000.00
DDS income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 1268222000.00
DDS balance_sheet (annual, 2026-01-31) — Current Accrued Expenses: 151714000.00
DDS balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 151714000.00
DDS balance_sheet (annual, 2026-01-31) — Current Assets: 2386571000.00
DDS balance_sheet (quarterly, 2026-01-31) — Current Assets: 2386571000.00
DDS balance_sheet (annual, 2026-01-31) — Current Capital Lease Obligation: 9547000.00
DDS balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 9547000.00
DDS balance_sheet (annual, 2026-01-31) — Current Debt: 96000000.00
DDS balance_sheet (quarterly, 2026-01-31) — Current Debt: 96000000.00
DDS balance_sheet (annual, 2026-01-31) — Current Debt And Capital Lease Obligation: 105547000.00
DDS balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 105547000.00
DDS balance_sheet (annual, 2026-01-31) — Current Liabilities: 902084000.00
DDS balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 902084000.00
DDS cash_flow (annual, 2026-01-31) — Deferred Income Tax: -7308000.00
DDS cash_flow (annual, 2026-01-31) — Deferred Tax: -7308000.00
DDS cash_flow (annual, 2026-01-31) — Depreciation: 180862000.00
DDS cash_flow (quarterly, 2026-01-31) — Depreciation: 46212000.00
DDS cash_flow (annual, 2026-01-31) — Depreciation Amortization Depletion: 180862000.00
DDS cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 46212000.00
DDS income_statement (annual, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 179341000.00
DDS income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 45822000.00
DDS cash_flow (annual, 2026-01-31) — Depreciation And Amortization: 180862000.00
DDS cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 46212000.00
DDS income_statement (annual, 2026-01-31) — Depreciation And Amortization In Income Statement: 179341000.00
DDS income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 45822000.00
DDS income_statement (annual, 2026-01-31) — Diluted Average Shares: 15700000.00
DDS income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 15600000.00
DDS income_statement (annual, 2026-01-31) — Diluted EPS: 36.42
DDS income_statement (quarterly, 2026-01-31) — Diluted EPS: 13.05
DDS income_statement (annual, 2026-01-31) — Diluted NI Availto Com Stockholders: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 203725000.00
DDS income_statement (annual, 2026-01-31) — EBIT: 735511000.00
DDS income_statement (quarterly, 2026-01-31) — EBIT: 253488000.00
DDS income_statement (annual, 2026-01-31) — EBITDA: 916373000.00
DDS income_statement (quarterly, 2026-01-31) — EBITDA: 299700000.00
DDS income_statement (annual, 2026-01-31) — Earnings From Equity Interest Net Of Tax: 407000.00
DDS cash_flow (annual, 2026-01-31) — End Cash Position: 861460000.00
DDS cash_flow (quarterly, 2026-01-31) — End Cash Position: 861460000.00
DDS cash_flow (annual, 2026-01-31) — Financing Cash Flow: -595939000.00
DDS cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -473043000.00
DDS balance_sheet (annual, 2026-01-31) — Finished Goods: 1201098000.00
DDS balance_sheet (quarterly, 2026-01-31) — Finished Goods: 1201098000.00
DDS cash_flow (annual, 2026-01-31) — Free Cash Flow: 623626000.00
DDS cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 191609000.00
DDS income_statement (annual, 2026-01-31) — Gain On Sale Of Ppe: 20373000.00
DDS income_statement (quarterly, 2026-01-31) — Gain On Sale Of Ppe: 14896000.00
DDS balance_sheet (annual, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: -46674000.00
DDS balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: -46674000.00
DDS income_statement (annual, 2026-01-31) — General And Administrative Expense: 1778459000.00
DDS income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 468694000.00
DDS balance_sheet (annual, 2026-01-31) — Gross PPE: 3826767000.00
DDS balance_sheet (quarterly, 2026-01-31) — Gross PPE: 3826767000.00
DDS income_statement (annual, 2026-01-31) — Gross Profit: 2646474000.00
DDS income_statement (quarterly, 2026-01-31) — Gross Profit: 721167000.00
DDS balance_sheet (annual, 2026-01-31) — Income Tax Payable: 24139000.00
DDS balance_sheet (quarterly, 2026-01-31) — Income Tax Payable: 24139000.00
DDS income_statement (annual, 2026-01-31) — Interest Expense: 41031000.00
DDS income_statement (annual, 2026-01-31) — Interest Expense Non Operating: 41031000.00
DDS income_statement (annual, 2026-01-31) — Interest Income: 47261000.00
DDS income_statement (quarterly, 2026-01-31) — Interest Income: 41906000.00
DDS income_statement (annual, 2026-01-31) — Interest Income Non Operating: 47261000.00
DDS income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 41906000.00
DDS balance_sheet (annual, 2026-01-31) — Interest Payable: 7174000.00
DDS balance_sheet (quarterly, 2026-01-31) — Interest Payable: 7174000.00
DDS balance_sheet (annual, 2026-01-31) — Inventory: 1201098000.00
DDS balance_sheet (quarterly, 2026-01-31) — Inventory: 1201098000.00
DDS balance_sheet (annual, 2026-01-31) — Invested Capital: 2300644000.00
DDS balance_sheet (quarterly, 2026-01-31) — Invested Capital: 2300644000.00
DDS cash_flow (annual, 2026-01-31) — Investing Cash Flow: 22537000.00
DDS cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -25851000.00
DDS balance_sheet (annual, 2026-01-31) — Land And Improvements: 47183000.00
DDS balance_sheet (quarterly, 2026-01-31) — Land And Improvements: 47183000.00
DDS balance_sheet (annual, 2026-01-31) — Long Term Capital Lease Obligation: 26341000.00
DDS balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 26341000.00
DDS balance_sheet (annual, 2026-01-31) — Long Term Debt: 425674000.00
DDS balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 425674000.00
DDS balance_sheet (annual, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 452015000.00
DDS balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 452015000.00
DDS balance_sheet (annual, 2026-01-31) — Machinery Furniture Equipment: 638337000.00
DDS balance_sheet (quarterly, 2026-01-31) — Machinery Furniture Equipment: 638337000.00
DDS cash_flow (annual, 2026-01-31) — Net Business Purchase And Sale: -34305000.00
DDS cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: 0.00
DDS cash_flow (annual, 2026-01-31) — Net Common Stock Issuance: -107756000.00
DDS cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 0.00
DDS income_statement (annual, 2026-01-31) — Net Income: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Net Income: 203725000.00
DDS income_statement (annual, 2026-01-31) — Net Income Common Stockholders: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 203725000.00
DDS income_statement (annual, 2026-01-31) — Net Income Continuous Operations: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 203725000.00
DDS income_statement (annual, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 203725000.00
DDS income_statement (annual, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 203725000.00
DDS cash_flow (annual, 2026-01-31) — Net Income From Continuing Operations: 570187000.00
DDS cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 203725000.00
DDS income_statement (annual, 2026-01-31) — Net Income Including Noncontrolling Interests: 570187000.00
DDS income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 203725000.00
DDS income_statement (annual, 2026-01-31) — Net Interest Income: 6230000.00
DDS income_statement (quarterly, 2026-01-31) — Net Interest Income: 875000.00
DDS cash_flow (annual, 2026-01-31) — Net Investment Purchase And Sale: 122960000.00
DDS cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: -24443000.00
DDS income_statement (annual, 2026-01-31) — Net Non Operating Interest Income Expense: 6230000.00
DDS income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 875000.00
DDS cash_flow (annual, 2026-01-31) — Net Other Financing Charges: -3307000.00
DDS cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: 29000.00
DDS cash_flow (annual, 2026-01-31) — Net Other Investing Changes: 27264000.00
DDS cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: 18136000.00
DDS balance_sheet (annual, 2026-01-31) — Net PPE: 947983000.00
DDS balance_sheet (quarterly, 2026-01-31) — Net PPE: 947983000.00
DDS cash_flow (annual, 2026-01-31) — Net PPE Purchase And Sale: -93382000.00
DDS cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -19544000.00
DDS balance_sheet (annual, 2026-01-31) — Net Tangible Assets: 1778970000.00
DDS balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 1778970000.00
DDS balance_sheet (annual, 2026-01-31) — Non Current Deferred Assets: 77386000.00
DDS balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Assets: 77386000.00
DDS balance_sheet (annual, 2026-01-31) — Non Current Deferred Taxes Assets: 77386000.00
DDS balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Assets: 77386000.00
DDS income_statement (annual, 2026-01-31) — Normalized EBITDA: 896000000.00
DDS income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 284804000.00
DDS income_statement (annual, 2026-01-31) — Normalized Income: 553460767.00
DDS income_statement (quarterly, 2026-01-31) — Normalized Income: 189793113.57
DDS cash_flow (annual, 2026-01-31) — Operating Cash Flow: 717008000.00
DDS cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 211153000.00
DDS cash_flow (annual, 2026-01-31) — Operating Gains Losses: -20373000.00
DDS cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: -14896000.00
DDS income_statement (annual, 2026-01-31) — Operating Income: 688674000.00
DDS income_statement (quarterly, 2026-01-31) — Operating Income: 206651000.00
DDS income_statement (annual, 2026-01-31) — Operating Revenue: 6563336000.00
DDS income_statement (quarterly, 2026-01-31) — Operating Revenue: 1989389000.00
DDS balance_sheet (annual, 2026-01-31) — Ordinary Shares Number: 15617071.00
DDS balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 15617071.00
DDS balance_sheet (annual, 2026-01-31) — Other Current Assets: 72792000.00
DDS balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 72792000.00